Migraine - US Drug Forecast and Market Analysis to 2023

www.MarketResearchReports.com

PharmaPoint: Migraine - US Drug Forecast

and Market Analysis to 2023

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

http://www.marketresearchreports.com/


Introduction to Report

Launch Date: March 31, 2014

Number of Pages: 143

Geography Coverage: USA

Available Format: PDF

Price For Single User License: USD 4,995

Price For Site User License: USD 9,990

Price For Global User License: USD 14,985

Delivery Time: Within 24 Hours (During Working Days)



About the Report

The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth.

By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.



Scope Overview of Migraine including epidemiology, etiology,

symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.

Sales forecast for the top drugs in the US from 2012-2023.

Analysis of the impact of key events as well the drivers and restraints affecting the US Migraine market.



Reasons to Buy Understand and capitalize by identifying products that

are most likely to ensure a robust return

Stay ahead of the competition by understanding the changing competitive landscape for Migraine

Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

Make more informed business decisions from insightful and in-depth analysis of drug performance

Obtain sales forecast for drugs from 2012-2023 in the US



Report Coverage

1. Table of Contents2. Introduction3. Disease Overview4. Disease Management5. Competitive Assessment6. Opportunity and Unmet Need7. Pipeline Assessment8. Market Outlook9. Appendix

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.



Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/idea-center



How To Buy This Report?Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/ZTp

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/ZTp

http://mrr.cm/ZTp

mailto:[email protected]
